LEQSELVI vs TOFACITINIB CITRATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. LEQSELVI and TOFACITINIB CITRATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LEQSELVI	TOFACITINIB CITRATE
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DEURUXOLITINIB PHOSPHATE	TOFACITINIB CITRATE
Manufacturer	Sun Pharm Inds Inc	Somerset Theraps LLC
Dosage forms	Tablet	Tablet, extended release
Drug class	Janus Kinase Inhibitor	Janus Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Alopecia Areata	Rheumatoid Arthritis

leqselvi tofacitinib citrate

Rating

New

Pharmacy pays

—

Type

Active ingredient

DEURUXOLITINIB PHOSPHATE

TOFACITINIB CITRATE

Manufacturer

Sun Pharm Inds Inc

Somerset Theraps LLC

Dosage forms

Tablet

Tablet, extended release

Drug class

Janus Kinase Inhibitor

Boxed warning

Treats

Alopecia Areata

Rheumatoid Arthritis

Frequently asked questions

What is the difference between Leqselvi and Tofacitinib Citrate?

Leqselvi contains Deuruxolitinib Phosphate, while Tofacitinib Citrate contains Tofacitinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.